Fig. 2From: Dual action of epigallocatechin-3-gallate in virus-induced cell InjuryStage of antiviral activity of EGCG. The EGCG (50 μM) has been tested against SARS-CoV-2 (a) and HSV-2 (b) at different stages of the viral replication cycle including cell-free status “virucidal effect”, adsorption inhibition, and interference with viral replicationBack to article page